298 related articles for article (PubMed ID: 3919944)
1. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
Kessel D; Wilberding C
Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
[TBL] [Abstract][Full Text] [Related]
2. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
Kessel D; Wilberding C
Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
[TBL] [Abstract][Full Text] [Related]
3. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
[TBL] [Abstract][Full Text] [Related]
4. Interactions between calcium antagonists, calcium fluxes and anthracycline transport.
Kessel D; Wilberding C
Cancer Lett; 1984 Nov; 25(1):97-101. PubMed ID: 6097354
[TBL] [Abstract][Full Text] [Related]
5. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
7. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
Johnson RK; Chitnis MP; Embrey WM; Gregory EB
Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
[TBL] [Abstract][Full Text] [Related]
8. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
Chou TH; Kessel D
Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
[No Abstract] [Full Text] [Related]
9. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
Ramu A; Fuks Z; Gatt S; Glaubiger D
Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of calcium antagonists which alter anthracycline resistance.
Kessel D; Wilberding C
Biochem Pharmacol; 1984 Apr; 33(7):1157-60. PubMed ID: 6585204
[No Abstract] [Full Text] [Related]
11. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
Inaba M; Nagashima K; Sakurai Y; Fukui M; Yanagi Y
Gan; 1984 Dec; 75(12):1049-52. PubMed ID: 6597118
[TBL] [Abstract][Full Text] [Related]
12. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Inaba M; Nagashima K
Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
[TBL] [Abstract][Full Text] [Related]
13. Biochemical mechanism for resistance to anthracycline antibiotics.
Inaba M
Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
[No Abstract] [Full Text] [Related]
14. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
Ramu A; Shan TC; Glaubiger D
Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
16. Cellular accumulation and disposition of aclacinomycin A.
Egorin MJ; Clawson RE; Ross LA; Schlossberger NM; Bachur NR
Cancer Res; 1979 Nov; 39(11):4396-400. PubMed ID: 498071
[TBL] [Abstract][Full Text] [Related]
17. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
[TBL] [Abstract][Full Text] [Related]
18. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
19. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
20. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
Gupta S; Patel K; Singh H; Gollapudi S
Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
